kit for the preparation of technetium tc 99m albumin aggregated
PULMOTECH MAA (kit for the preparation of technetium tc 99m albumin aggregated) by Jubilant Therapeutics is 1 to 5 minutes of intravenous injection, over 90 percent of the technetium tc 99m albumin aggregated particles are trapped in the arterioles and capillaries of the lung. First approved in 2020.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
PULMOTECH MAA is a kit for preparing Technetium Tc 99m albumin aggregated, a diagnostic radiopharmaceutical used in nuclear medicine imaging. Administered intravenously, over 90% of particles are trapped in lung arterioles and capillaries, enabling pulmonary perfusion imaging; when given intraperitoneally, it assesses peritoneal shunt patency. This is a specialized imaging agent for detecting pulmonary emboli and evaluating peritoneal-venous shunt function.
Product is at peak commercial stage with moderate competitive pressure (30); niche diagnostic market with specialized distribution and smaller team requirements compared to primary care therapeutics.
1 to 5 minutes of intravenous injection, over 90 percent of the technetium Tc 99m albumin aggregated particles are trapped in the arterioles and capillaries of the lung. Following intraperitoneal administration, technetium Tc 99m albumin aggregated mixes with the peritoneal fluid. Clearance from…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Careers linked to PULMOTECH MAA are specialized within nuclear medicine and diagnostic imaging, a niche sector with smaller but focused teams. Working on this product develops expertise in regulatory-intensive diagnostics and hospital-based distribution, with limited but stable career progression in specialized imaging.
Worked on PULMOTECH MAA at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.